Immatics (IMTX) Other financing activities (2019 - 2024)

Immatics (IMTX) posted Other financing activities of -$201.9 million for Q4 2024, down 692.04% sequentially from $34.1 million in Q3 2024, and down 125.49% YoY from $792.1 million in Q1 2024.

Immatics (IMTX) Other financing activities (2019 - 2024) Analysis & Trends

Immatics has reported Other financing activities for 6 years, with the latest figure at -$201.9 million in Q4 2024.

  • Quarterly Other financing activities fell 125.49% year-over-year to -$201.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.6 million (up 823.53% YoY) and the FY2024 annual result came in at $256241.4, up 8.43% from the prior year.
  • Other financing activities slipped to -$201.9 million in Q4 2024 per IMTX's latest filing, from $34.1 million in the prior quarter.
  • Over five years, Other financing activities peaked at $244.0 billion in Q3 2020 and troughed at -$247.4 billion in Q4 2020.
  • A 5-year average of -$300.3 million and a median of -$30.1 million in 2022 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2020 and 2023: Other financing activities jumped 43784.24% in 2020, then tumbled 197.25% in 2023.
  • Over 5 years, Other financing activities stood at -$247.4 billion in 2020, then soared by 99.77% to -$581.4 million in 2021, then jumped by 94.82% to -$30.1 million in 2022, then sank by 197.25% to -$89.5 million in 2023, then plunged by 125.49% to -$201.9 million in 2024.
  • According to Business Quant data, Other financing activities over the past three periods registered -$201.9 million, $34.1 million, and $38.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immatics 1.27 Bn 719.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -201.92 Mn
Dec 31, 2024 -201.92 Mn
Sep 30, 2024 34.11 Mn
Sep 30, 2024 34.11 Mn
Jun 30, 2024 38.82 Mn
Jun 30, 2024 38.82 Mn
Mar 31, 2024 132.64 Mn
Mar 31, 2024 132.64 Mn
Dec 31, 2023 -89.55 Mn
Dec 31, 2023 -89.55 Mn
Sep 30, 2023 -51.12 Mn
Sep 30, 2023 -51.12 Mn
Jun 30, 2023 13.60 Mn
Jun 30, 2023 13.60 Mn
Mar 31, 2023 126.57 Mn
Mar 31, 2023 126.57 Mn
Dec 31, 2022 -30.13 Mn
Dec 31, 2022 -30.13 Mn
Sep 30, 2022 -87.80 Mn
Sep 30, 2022 -87.80 Mn